Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 4, 2017
Circulating syndecans during critical illnessAxel Nelson, Joakim Johansson, Jonas Tydén, et al.Microvascular Research|September 13, 2011
Effect of charge on microvascular permeability in early experimental sepsis in the ratPeter Bansch, Axel Nelson, Tomas Ohlsson, et al.Journal of Innate Immunity|June 24, 2010
Elevated plasma levels of antimicrobial polypeptides in patients with severe sepsisIngrid Berkestedt, Heiko Herwald, Lennart Ljunggren, et al.Shock (Augusta, Ga.)|May 24, 2008
Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasmaAxel Nelson, Ingrid Berkestedt, Artur Schmidtchen, et al.Leukemia & Lymphoma|September 6, 2007
A limited number of IgH-primers binding to framework region 1 is sufficient to detect the majority of mature small B-cell non-Hodgkin lymphomas on formalin-fixed paraffin-embedded tissue by PCRDick Nelson, Axel Nelson, Lena Hjorthagen, et al.Intensive Care Medicine Experimental|March 5, 2016
Effects of fresh frozen plasma, Ringer's acetate and albumin on plasma volume and on circulating glycocalyx components following haemorrhagic shock in ratsAxel Nelson, Svajunas Statkevicius, Ulf Schött, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 24, 2026
Nodal localisation with magnetic seed in patients with stage III melanoma receiving neoadjuvant immune checkpoint inhibitors, a feasibility studyEllen Krabbe, Anne Huibers, Lars Ny, et al.Cancers|May 13, 2026
Selecting Representative Tumour Bed Slices May Allow Reduced Embedding Without Loss of Accuracy in Response Evaluation to Neoadjuvant Immunotherapy in Stage IIIB/C Cutaneous MelanomaAnders Bergström, Axel Nelson, Anne Huibers, et al.European Journal of Cancer (Oxford, England : 1990)|June 2, 2025
Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma - A Swedish retrospective real-world study (NEO-MEL)Axel Nelson, Ellen Krabbe, Karl Björkström, et al.Annals of Surgery|July 29, 2026
Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma-Different Outcomes Between Patients With Lymph Node and In-transit MetastasesEllen Krabbe, Anne Huibers, Ana Carneiro, et al.Pageof 2